Sharon Johnson

2017

In 2017, Sharon Johnson earned a total compensation of $2.1M as Senior Vice President, Quality &Regulatory Affairs at Catalent, a 57% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$292,530
Option Awards$231,271
Salary$368,857
Stock Awards$672,479
Other$524,097
Total$2,089,234

Johnson received $672.5K in stock awards, accounting for 32% of the total pay in 2017.

Johnson also received $292.5K in non-equity incentive plan, $231.3K in option awards, $368.9K in salary and $524.1K in other compensation.

Rankings

In 2017, Sharon Johnson's compensation ranked 5,290th out of 14,666 executives tracked by ExecPay. In other words, Johnson earned more than 63.9% of executives.

ClassificationRankingPercentile
All
5,290
out of 14,666
64th
Division
Manufacturing
1,889
out of 5,768
67th
Major group
Chemicals And Allied Products
560
out of 2,074
73rd
Industry group
Drugs
432
out of 1,730
75th
Industry
Pharmaceutical Preparations
340
out of 1,329
74th
Source: SEC filing on September 22, 2017.

Johnson's colleagues

We found five more compensation records of executives who worked with Sharon Johnson at Catalent in 2017.

2017

John Chiminski

Catalent

Chief Executive Officer

2017

Matthew Walsh

Catalent

Chief Financial Officer

2017

William Downie

Catalent

Senior Vice President, Sales and Marketing

2017

Steven Fasman

Catalent

General Counsel

2017

Barry Littlejohns

Catalent

President, Drug Delivery Solutions

You may also like